id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-D-0241-0001,FDA,FDA-2021-D-0241,Inspection of Injectable Products for Visible Particulates; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2021-12-17T05:00:00Z,2021,12,2021-12-17T05:00:00Z,2022-02-16T04:59:59Z,2022-03-13T00:07:08Z,2021-27351,0,0,0900006484ed1d58
FDA-2021-D-0241-0002,FDA,FDA-2021-D-0241,Inspection of Injectable Products for Visible Particulates Guidance for Industry DRAFT GUIDANCE,Other,Guidance,2021-12-17T05:00:00Z,2021,12,2021-12-17T05:00:00Z,2022-02-16T04:59:59Z,2024-11-07T00:35:57Z,,1,0,0900006484ed2edf